North Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Buy
1,554
+25
+2% +$5.83K 0.3% 55
2026
Q1
$374K Hold
1,529
0.32% 51
2025
Q4
$316K Sell
1,529
-37
-2% -$7.32K 0.27% 58
2025
Q3
$290K Buy
1,566
+121
+8% +$20.7K 0.22% 58
2025
Q2
$221K Sell
1,445
-12
-0.8% -$1.84K 0.19% 71
2025
Q1
$242K Buy
+1,457
New +$228K 0.23% 62

Other funds holding JNJ

North Capital's JNJ Position: Q2 2026 in Review

North Capital increased its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, buying an estimated $5.83K and bringing the position to 1,554 shares worth $395K. The position accounts for 0.3% of the portfolio, ranked #55.

North Capital first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • North Capital held 1,554 shares of Johnson & Johnson worth $395K as of Q2 2026.
  • North Capital bought 25 Johnson & Johnson shares in Q2 2026, an estimated $5.83K.
  • Johnson & Johnson made up 0.3% of North Capital's portfolio in Q2 2026, its #55 holding.
  • North Capital first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on North Capital's 13F filing for Q2 2026, filed 14 Jul 2026.